A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer

PURPOSE: In spite of increased rates of complete response to initial chemotherapy, most patients with advanced ovarian cancer relapse and succumb to progressive disease. RATIONALE: Genetically reprogrammed, patient-derived chimeric antigen receptor (CAR)-T lymphocytes with the ability to recognize p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandalaft, Lana E, Powell, Daniel J, Coukos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439340/
https://www.ncbi.nlm.nih.gov/pubmed/22863016
http://dx.doi.org/10.1186/1479-5876-10-157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439340/
https://www.ncbi.nlm.nih.gov/pubmed/22863016
http://dx.doi.org/10.1186/1479-5876-10-157

Ejemplares similares